Hironic, Q1 Sales of 7.9 Billion Won... Up 39.7% YoY

Hironic, a specialized beauty medical device company, announced on the 16th that it achieved sales of 7.9 billion KRW, operating profit of 1.3 billion KRW, and net profit of 1.0 billion KRW in the first quarter based on consolidated financial statements.

According to the consolidated financial statements, first-quarter sales increased by 39.7%, operating profit by 58.9%, and net profit grew significantly by 326.6% compared to the same period last year, achieving strong performance.

The company explained that this strong performance was largely due to significant growth in export results. Hironic's domestic business division sales in the first quarter reached 3.4 billion KRW, growing by 11.0%, while export sales grew by 72.7% to 4.5 billion KRW.

By export region, sales in North America increased by 2380% compared to the same period last year, South America grew by 967.2%, and sales in Japan, Southeast Asia, and Europe also grew by 148.3%, 103.2%, and 75.6%, respectively.

In particular, the South American market saw first-quarter sales of approximately 900 million KRW, a tenfold increase from 100 million KRW in the same period last year. The company stated that the certification of key medical devices in South American markets such as Brazil and Peru was completed in the second quarter, making the sales growth before certification very encouraging, and they expect full-scale sales growth from the second quarter onward.

Additionally, the domestic sales of the flagship new product, the focused ultrasound stimulation system ‘Viro 2.0 (New Doublo 2.0)’, recorded 1.6 billion KRW, growing by 358.8%, indicating that the effect of the new product is becoming substantial, the company explained. Since ‘Viro 2.0 (New Doublo 2.0)’ is currently undergoing certification procedures in major countries, significant export growth is also expected as the number of certified countries expands.

Following the rapid growth of the home beauty device market, ‘HomeCera’ also contributed to the strong performance by growing 125.0% compared to the same period last year. ‘HomeCera’ is a home beauty device that helps with collagen production, pore tightening, skin elasticity improvement, and wrinkle reduction using patented high-intensity focused ultrasound (HIFU) technology.

A company representative said, “From this year, consumables sales growth is becoming more active, and through the growth of domestic and overseas performance of flagship new products and proactive exploration of new overseas markets, we will achieve meaningful performance growth. In particular, we will secure new growth engines through the expansion of new product lineups in the home beauty device category this year.”

This content was produced with the assistance of AI translation services.